Market News
Aon Releases Q3 2025 Global Insurance Market Insights Report
Aon's Q3 2025 report highlights widespread softening across property, cyber, and directors and officers due to strong capacity and competition. US casualty remains difficult as loss severity and litigation continue to rise. Buyers are encouraged to use current conditions to strengthen programs, review limits, and reinvest savings in long-term resilience. Read More
AM Best Revises Outlook on US E&S Lines to Stable
AM Best has revised its outlook for the US excess and surplus (E&S) lines insurance segment from positive to stable, citing rate softening, slower premium growth, and tightening capacity. Despite ongoing demand and profitability, operational challenges and increased scrutiny in fronted programs signal more cautious conditions for insurers operating in this market. Read More
Commercial Renewal Rates Rise in October Except for Workers Comp
Premium renewal rates across most major commercial lines increased in October 2025 compared to both the prior month and the previous year, according to the latest Ivans Index data. The only exception was workers compensation, which continued its downward trend. Read More
Inside the Captive Feasibility Study Process
Before launching a captive insurance company, organizations conduct a feasibility study to assess purpose, risks, structure, and domicile options. This video breaks down the process, including actuarial analysis and pro forma financial modeling, and explains how the study informs decision-making and regulatory approval while shaping future program direction. Read More
Regulatory Shifts Are Reshaping the European Captive Insurance Market
AM Best's latest report outlines how regulatory reforms, market conditions, and evolving domicile activity are influencing the European captive insurance market. Captives continue to expand coverage, adjust reinsurance strategies, and benefit from strong capitalization. Solvency II amendments and new national frameworks are expected to further shape the sector through 2027. Read More